In addition, hCG in combination with other biomarkers, such as pregnancy-associated plasma protein A (PAPP-A), alpha fetoprotein (AFP), inhibin-A and unconjugated estriol (uE3) is used in prenatal screening tests for chromosome abnormality, where high levels of hCG are indicative for, such as Down syndrome. The gene discussed is PAPPA; the disease is Down syndrome.